- DNA polymerase
- Acetylases
- DNA ligases
- Methyltransferase
- RNA ligases
- Reverse Transcriptase
- Others
Epigenetics Market size was valued at US$ 823 Million in 2022 and is projected to reach US$ 2021.73 Million at a CAGR of 13.7% from 2023- 2029. Epigenetics is a study of heritable changes in gene expression which involves the change in phenotype without changing genotype, which in turn affects the reading of genes by cells. Epigenetic changes are natural and regular processes but are also influenced by various factors like lifestyle, environment, age, and state of disease. Epigenetic modifications can manifest a common manner of cells that differentiate terminally to end up as liver cells, skin cells, brain cells, etc. Epigenetic change may have more damaging effects which can lead to diseases like cancer. Systems like histone modification, non-coding RNA-associated gene silencing, and DNA methylation are considered for the initiation of epigenetic change sustainably. In October 2016 Episode an epigenetics data company launched SEED a novel male fertility test to evaluate epigenetic changes on DNA to detect a risk of infertility and poor embryo development.
Epigenetics Market Key Developments:
- In June 2011, Cayman chemical company adopted the Genedata screener of Genedata, the company of advanced software solutions for drug discovery and life science research as a data management platform for cayman's new epigenetic screening laboratory.
Global Epigenetics Market Summary
Study Period
2023-29
Base Year
2022
CAGR
13.7%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Epigenetics Market Dynamics
The surge in the prevalence of cancer, improving funds and aids for the R&D activities, rise in the partnerships between pharmaceutical and biotechnology companies and research institutes, increase in epigenetics application in non-oncology diseases will propel the epigenetics. Moreover, improved advancements in epigenetics technology, untapped potential of emerging markets like India and China are expected to offer many opportunities for the growth of epigenetics market. However, high instrument cost and the dearth of skilled personnel are expected to hamper the growth of the market.
North-America Got Significant Share
Epigenetics Market Regional Analysis
North America is expected to account for the largest market share in the regional market of epigenetics due to rise in prevalence of cancer, high funding on R&D, increasing acquisitions and collaborations among large pharma companies, high adaptation and awareness of new technologies and healthcare infrastructure. Asia Pacific is a lucrative market owing to the presence of favourable regulatory framework, high incidence and prevalence of diabetes, cancer and cardiovascular diseases among the population of Asia Pacific countries. Mexico, Brazil, and South Africa are expected to show significant growth due to rising economy, a high prevalence of diseases and presence of high unmet needs.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The epigenetics market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Epigenetics Market Segmentation
By Enzymes
By Instruments
- Next generation sequencers
- Mass spectrometers
- Sonicators
- qPCRs
- Others
By Application
- Oncology
- Cardiovascular Diseases
- Metabolic Diseases
- Inflammatory Diseases
- Infectious Diseases
By Kits and Assays
- Deep Sequencing Kit
- Bisulfate Conversion Kit
- Methyltransferase Assays
- Chip- Seq Kits
- Immunoprecipitation Kits
- Histone Assay
By End User
- Pharmaceutical and Biotechnological Companies
- Contract Research Companies
- Academic and Research Institutes
Frequently Asked Questions
The epigenetics market key players are: Illumina, Inc. (U.S.), Abcam plc. (U.K), QIAGEN N.V. (Netherland), New England Biolabs, Inc. (U.S.), Merck & Co. (U.S.), Sigma-Aldrich Corporation (U.S.), Genedata AG(Switzerland), Cayman chemical company (U.S), Active Motif (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Diagenode, Inc. (Belgium), Zymo Research Corporation (U.S.)., Episona Inc. (U.S).
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary |
| 2. Global Epigenetics Market Introduction |
| 2.1.Global Epigenetics Market - Taxonomy |
| 2.2.Global Epigenetics Market - Definitions |
| 2.2.1.Enzymes |
| 2.2.2.Instruments |
| 2.2.3.Application |
| 2.2.4.Kits and Assays |
| 2.2.5.Region |
| 3. Global Epigenetics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Epigenetics Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Epigenetics Market By Enzymes, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. DNA polymerase |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Acetylases |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. DNA ligases |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Methyltransferase |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. RNA ligases |
| 5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Reverse Transcriptase |
| 5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Others |
| 5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 6. Global Epigenetics Market By Instruments, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Next generation sequencers |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Mass spectrometers |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Sonicators |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. qPCRs |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Epigenetics Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Oncology |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cardiovascular Diseases |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Metabolic Diseases |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Inflammatory Diseases |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Infectious Diseases |
| 7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Epigenetics Market By Kits and Assays, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Deep Sequencing Kit |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Bisulfate Conversion Kit |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Methyltransferase Assays |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Chip- Seq Kits |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Immunoprecipitation Kits |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Histone Assay |
| 8.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.6.3. Market Opportunity Analysis |
| 9. Global Epigenetics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Enzymes Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.DNA polymerase |
| 10.1.2.Acetylases |
| 10.1.3.DNA ligases |
| 10.1.4.Methyltransferase |
| 10.1.5.RNA ligases |
| 10.1.6.Reverse Transcriptase |
| 10.1.7.Others |
| 10.2. Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Next generation sequencers |
| 10.2.2.Mass spectrometers |
| 10.2.3.Sonicators |
| 10.2.4.qPCRs |
| 10.2.5.Others |
| 10.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Oncology |
| 10.3.2.Cardiovascular Diseases |
| 10.3.3.Metabolic Diseases |
| 10.3.4.Inflammatory Diseases |
| 10.3.5.Infectious Diseases |
| 10.4. Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Deep Sequencing Kit |
| 10.4.2.Bisulfate Conversion Kit |
| 10.4.3.Methyltransferase Assays |
| 10.4.4.Chip- Seq Kits |
| 10.4.5.Immunoprecipitation Kits |
| 10.4.6.Histone Assay |
| 10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Enzymes Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.DNA polymerase |
| 11.1.2.Acetylases |
| 11.1.3.DNA ligases |
| 11.1.4.Methyltransferase |
| 11.1.5.RNA ligases |
| 11.1.6.Reverse Transcriptase |
| 11.1.7.Others |
| 11.2. Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Next generation sequencers |
| 11.2.2.Mass spectrometers |
| 11.2.3.Sonicators |
| 11.2.4.qPCRs |
| 11.2.5.Others |
| 11.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Oncology |
| 11.3.2.Cardiovascular Diseases |
| 11.3.3.Metabolic Diseases |
| 11.3.4.Inflammatory Diseases |
| 11.3.5.Infectious Diseases |
| 11.4. Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Deep Sequencing Kit |
| 11.4.2.Bisulfate Conversion Kit |
| 11.4.3.Methyltransferase Assays |
| 11.4.4.Chip- Seq Kits |
| 11.4.5.Immunoprecipitation Kits |
| 11.4.6.Histone Assay |
| 11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Enzymes Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.DNA polymerase |
| 12.1.2.Acetylases |
| 12.1.3.DNA ligases |
| 12.1.4.Methyltransferase |
| 12.1.5.RNA ligases |
| 12.1.6.Reverse Transcriptase |
| 12.1.7.Others |
| 12.2. Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Next generation sequencers |
| 12.2.2.Mass spectrometers |
| 12.2.3.Sonicators |
| 12.2.4.qPCRs |
| 12.2.5.Others |
| 12.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Oncology |
| 12.3.2.Cardiovascular Diseases |
| 12.3.3.Metabolic Diseases |
| 12.3.4.Inflammatory Diseases |
| 12.3.5.Infectious Diseases |
| 12.4. Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Deep Sequencing Kit |
| 12.4.2.Bisulfate Conversion Kit |
| 12.4.3.Methyltransferase Assays |
| 12.4.4.Chip- Seq Kits |
| 12.4.5.Immunoprecipitation Kits |
| 12.4.6.Histone Assay |
| 12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Enzymes Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.DNA polymerase |
| 13.1.2.Acetylases |
| 13.1.3.DNA ligases |
| 13.1.4.Methyltransferase |
| 13.1.5.RNA ligases |
| 13.1.6.Reverse Transcriptase |
| 13.1.7.Others |
| 13.2. Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Next generation sequencers |
| 13.2.2.Mass spectrometers |
| 13.2.3.Sonicators |
| 13.2.4.qPCRs |
| 13.2.5.Others |
| 13.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Oncology |
| 13.3.2.Cardiovascular Diseases |
| 13.3.3.Metabolic Diseases |
| 13.3.4.Inflammatory Diseases |
| 13.3.5.Infectious Diseases |
| 13.4. Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Deep Sequencing Kit |
| 13.4.2.Bisulfate Conversion Kit |
| 13.4.3.Methyltransferase Assays |
| 13.4.4.Chip- Seq Kits |
| 13.4.5.Immunoprecipitation Kits |
| 13.4.6.Histone Assay |
| 13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 14.1. Enzymes Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.DNA polymerase |
| 14.1.2.Acetylases |
| 14.1.3.DNA ligases |
| 14.1.4.Methyltransferase |
| 14.1.5.RNA ligases |
| 14.1.6.Reverse Transcriptase |
| 14.1.7.Others |
| 14.2. Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Next generation sequencers |
| 14.2.2.Mass spectrometers |
| 14.2.3.Sonicators |
| 14.2.4.qPCRs |
| 14.2.5.Others |
| 14.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Oncology |
| 14.3.2.Cardiovascular Diseases |
| 14.3.3.Metabolic Diseases |
| 14.3.4.Inflammatory Diseases |
| 14.3.5.Infectious Diseases |
| 14.4. Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Deep Sequencing Kit |
| 14.4.2.Bisulfate Conversion Kit |
| 14.4.3.Methyltransferase Assays |
| 14.4.4.Chip- Seq Kits |
| 14.4.5.Immunoprecipitation Kits |
| 14.4.6.Histone Assay |
| 14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Illumina, Inc. (U.S.) |
| 15.2.2.Abcam plc. (U.K) |
| 15.2.3.QIAGEN N.V. (Netherland) |
| 15.2.4.New England Biolabs, Inc. (U.S.) |
| 15.2.5.Merck & Co. (U.S.) |
| 15.2.6.Sigma-Aldrich Corporation (U.S.) |
| 15.2.7.Genedata AG(Switzerland) |
| 15.2.8.Cayman chemical company (U.S) |
| 15.2.9.Active Motif (U.S.) |
| 15.2.10.Thermo Fisher Scientific, Inc., (U.S.) |
| 15.2.11.Diagenode, Inc. (Belgium) |
| 15.2.12.Zymo Research Corporation (U.S.). |
| 15.2.13.Episona Inc. (U.S). |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Illumina, Inc. (U.S.)
- Abcam plc. (U.K)
- QIAGEN N.V. (Netherland)
- New England Biolabs, Inc. (U.S.)
- Merck & Co. (U.S.)
- Sigma-Aldrich Corporation (U.S.)
- Genedata AG(Switzerland)
- Cayman chemical company (U.S)
- Active Motif (U.S.)
- Thermo Fisher Scientific, Inc., (U.S.)
- Diagenode, Inc. (Belgium)
- Zymo Research Corporation (U.S.).
- Episona Inc. (U.S).